Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Financial Flexibility Index
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥298.34 Million (operating CF CN¥294.76 Million minus capex CN¥3.59 Million) represents 0% of total liabilities (CN¥3.00 Billion). Check Guizhou Bailing Group Pharmaceutical Co total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guizhou Bailing Group Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Guizhou Bailing Group Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Guizhou Bailing Group Pharmaceutical Co .
Annual Financial Flexibility Index for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Guizhou Bailing Group Pharmaceutical Co Ltd. Explore 002424 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥873.96 Million | CN¥748.72 Million | CN¥3.02 Billion | ▲ +2129.6% |
| 2024 | 0.01x | CN¥51.04 Million | CN¥9.02 Million | CN¥3.94 Billion | ▼ -78.4% |
| 2023 | 0.06x | CN¥229.89 Million | CN¥125.77 Million | CN¥3.82 Billion | ▼ -69.5% |
| 2022 | 0.20x | CN¥570.60 Million | CN¥502.15 Million | CN¥2.90 Billion | ▼ -33.6% |
| 2021 | 0.30x | CN¥750.65 Million | CN¥324.92 Million | CN¥2.53 Billion | ▲ +187.1% |
| 2020 | 0.10x | CN¥321.80 Million | CN¥231.78 Million | CN¥3.11 Billion | ▼ -48.9% |
| 2019 | 0.20x | CN¥589.32 Million | CN¥467.41 Million | CN¥2.91 Billion | ▲ +1559.9% |
| 2018 | -0.01x | CN¥-28.43 Million | CN¥-157.45 Million | CN¥2.05 Billion | ▼ -108.4% |
| 2017 | 0.17x | CN¥224.57 Million | CN¥79.88 Million | CN¥1.36 Billion | ▼ -69.0% |
| 2016 | 0.53x | CN¥625.95 Million | CN¥466.62 Million | CN¥1.17 Billion | ▲ +16.2% |
| 2015 | 0.46x | CN¥534.27 Million | CN¥413.23 Million | CN¥1.16 Billion | ▲ +13.8% |
| 2014 | 0.40x | CN¥492.32 Million | CN¥395.83 Million | CN¥1.22 Billion | ▲ +137.2% |
| 2013 | 0.17x | CN¥230.50 Million | CN¥141.76 Million | CN¥1.35 Billion | ▲ +2.3% |
| 2012 | 0.17x | CN¥199.68 Million | CN¥19.52 Million | CN¥1.20 Billion | ▼ -54.5% |
| 2011 | 0.37x | CN¥394.98 Million | CN¥201.90 Million | CN¥1.08 Billion | ▲ +223.7% |
| 2010 | -0.30x | CN¥-281.99 Million | CN¥-447.68 Million | CN¥952.49 Million | ▼ -189.6% |
| 2009 | 0.33x | CN¥147.22 Million | CN¥125.31 Million | CN¥445.48 Million | ▲ +485.3% |
| 2008 | -0.09x | CN¥-27.51 Million | CN¥-40.42 Million | CN¥320.72 Million | ▲ +63.2% |
| 2007 | -0.23x | CN¥-73.70 Million | CN¥-79.37 Million | CN¥315.87 Million | — |